Drugs and Devices

FDA approves Simponi for ulcerative colitis

May 15, the U.S. Food and Drug Administration (FDA) approved a new use for Simponi (golimumab) injection: to treat adults with moderate to severe ulcerative colitis. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares